Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Triple Negative Breast Cancer
Sponsor: Centre Jean Perrin